# Cochrane Risk of Bias 2 (RoB 2) Assessment

## Study & Result Information
- **Study Citation:** Lu Z, Wang X, Cheng J, et al. Acupoint Stimulation for Enhanced Recovery After Colon Surgery: A Prospective Multicenter Randomized Controlled Trial. Journal of Pain Research. 2022;15:1025–1036.
- **Source Document in Google Drive:** `getfile.php-3.pdf`
- **Trial Registration:** ClinicalTrials.gov NCT02921529
- **Population:** 240 patients (aged 18–75 years, ASA I–III) undergoing elective colon surgery across three tertiary academic hospitals.
- **Intervention:** TEAS applied to bilateral Zusanli (ST36) and Neiguan (PC6) twice daily for 30 minutes on POD 1 to POD 3 (dense-disperse 2/100 Hz, current 10–20 mA; n = 120 analyzed).
- **Comparator:** Control group receiving standardized ERAS perioperative care without acupoint stimulation (n = 120 analyzed).
- **Assessed Outcome:** Time to First Postoperative Flatus
- **Assessed Timepoint:** Postoperative Day 1 to Day 3
- **Numerical Result:**
  - Time to first flatus was significantly shorter in the TEAS group compared with the Control group (mean ± SD: 49.2 ± 13.8 h vs. 59.6 ± 15.2 h, P < 0.001). Time to first defecation (68.5 ± 18.2 h vs. 81.4 ± 21.6 h, P = 0.03) and total postoperative hospital stay were also significantly reduced.

---

### Step 1: Study Design Verification
- **Experimental Design:** Prospective, multicenter, randomized, assessor-blinded, open-label controlled parallel-group trial (1:1 ratio).
- **Unit of Randomization:** Individual patient.

---

### Step 2: Signaling Questions & Domain Evaluations

#### Domain 1: Risk of bias arising from the randomization process
- **1.1 Random sequence generation:** Yes (Y)
  - **Evidence:** "Randomization was generated using a central SAS-based web system with block size of 4." (p. 1026, col. 2).
- **1.2 Allocation concealment:** Yes (Y)
  - **Evidence:** "Allocation concealment was ensured through the central web-based automated randomization portal." (p. 1026, col. 2).
- **1.3 Baseline balance:** No (N)
  - **Evidence:** Patient demographics, surgical resection site, operative time, and intraoperative fluid volumes were balanced (P > 0.05; Table 1).
- **Domain 1 Judgment:** **Low Risk of Bias**

#### Domain 2: Risk of bias due to deviations from the intended interventions
- **2.1 Participant awareness:** Yes (Y)
  - **Evidence:** Open-label design comparing TEAS against standard ERAS care without sham stimulation; participants were aware of receiving TEAS.
- **2.2 Carers awareness:** Probably Yes (PY)
  - **Evidence:** Bedside nurses delivering care could observe TEAS electrodes and stimulator devices.
- **2.3 Contextual deviations:** Probably No (PN)
  - **Evidence:** Identical standardized ERAS postoperative protocols followed across both arms.
- **2.5 Appropriate analysis:** Yes (Y)
  - **Evidence:** 240 randomized (120 TEAS, 120 Control); all 240 analyzed in the primary analysis (100% ITT).
- **Domain 2 Judgment:** **Some concerns Risk of Bias**

#### Domain 3: Risk of bias due to missing outcome data
- **3.1 Data completeness:** Yes (Y)
  - **Evidence:** Complete gastrointestinal recovery follow-up available for all 240 patients (100% complete data).
- **Domain 3 Judgment:** **Low Risk of Bias**

#### Domain 4: Risk of bias in measurement of the outcome
- **4.1 Inappropriate measurement:** No (N)
  - **Evidence:** Time to flatus recorded in hours through combined nurse-validated records and electronic patient diaries.
- **4.2 Differ between groups:** No (N)
  - **Evidence:** Identical recording protocols across groups.
- **4.3 Assessors aware:** Probably No (PN)
  - **Evidence:** "Outcome assessors recording recovery milestones and analyzing data were blinded to treatment allocation." (p. 1027, col. 1).
- **Domain 4 Judgment:** **Low Risk of Bias**

#### Domain 5: Risk of bias in selection of the reported result
- **5.1 Pre-specified analysis plan:** Yes (Y)
  - **Evidence:** Prospectively registered at ClinicalTrials.gov (NCT02921529).
- **5.2 Result selected:** No (N)
  - **Evidence:** Primary outcomes (time to flatus, defecation, length of stay) reported as pre-specified.
- **5.3 Multiple analyses:** No (N)
  - **Evidence:** Standard pre-specified survival and continuous analyses.
- **Domain 5 Judgment:** **Low Risk of Bias**

---

### Step 3: Overall Judgment & Summary Table

| Domain | Judgment | Key Supporting Rationale |
|---|:---:|---|
| **Domain 1: Randomization Process** | **Low** | Central web-based random sequence generation and allocation concealment. |
| **Domain 2: Deviations from Intended Interventions** | **Some concerns** | Open-label design without sham control; participants and bedside carers aware of intervention. |
| **Domain 3: Missing Outcome Data** | **Low** | Zero loss to follow-up. |
| **Domain 4: Measurement of the Outcome** | **Low** | Nurse-verified objective timing and blinded outcome evaluators. |
| **Domain 5: Selection of the Reported Result** | **Low** | Prospective registry (NCT02921529) with complete reporting. |
| **OVERALL RISK OF BIAS** | **SOME CONCERNS** | Some concerns in Domain 2 due to open-label design without sham comparator. |

---

### Step 4: Evidence Audit
- getfile.php-3.pdf, p. 1026, col. 2: "Allocation concealment was ensured through the central web-based automated randomization portal..."
- getfile.php-3.pdf, p. 1029, Table 2: "Time to first flatus: TEAS 49.2 ± 13.8 h vs. Control 59.6 ± 15.2 h, P < 0.001."

---

### Step 5: Author Contact Flags
- None.

---

### Step 6: Final Structured Extraction
```json
{
  "study_id": "Lu_2022",
  "source_file": "getfile.php-3.pdf",
  "trial_registration": "NCT02921529",
  "outcome": "Time to first flatus",
  "timepoint": "Postoperative Day 1 to Day 3",
  "sample_size": {
    "teas": 120,
    "control": 120,
    "total": 240
  },
  "result": {
    "teas_mean": 49.2,
    "teas_sd": 13.8,
    "control_mean": 59.6,
    "control_sd": 15.2,
    "p_value": "<0.001"
  },
  "overall_rob": "Some concerns"
}
```
